How to Check Any New Medicine — Against Your Cancer Drug

Yes, and it is one of the most consistently flagged interactions in oncology. Grapefruit contains compounds that block CYP3A4, the liver enzyme that breaks down many cancer drugs. Even a single glass can suppress that enzyme for many hours, meaning your cancer drug stays in your blood longer and at higher levels than intended. NCCN guidance flags grapefruit as a concern across multiple targeted therapy drug classes. Avoid grapefruit and grapefruit juice unless your team has specifically told you it is safe with your drug.

Paracetamol is not a CYP3A4 interactor and is generally considered lower-risk than ibuprofen or other NSAIDs for people on cancer treatment. However, the safe answer for your situation still depends on your specific cancer drug, your liver function, and the dose. Ask your oncology team which pain relief is safe for you, and at what dose, before you need it — not at 2am when you have a fever. Having a clear answer in advance is much safer than guessing in the moment.

Tell your cancer team about every herbal or traditional preparation you are taking or considering. This is not because they are all unsafe — it is because most have not been studied rigorously alongside cancer drugs, which means the interaction is unknown rather than proven safe. St. John's Wort is the most documented example of a herbal supplement that significantly reduces cancer drug levels, but it is not the only one. Your team cannot check for an interaction they do not know about. Telling them is not giving up the preparation — it is letting them help you use it as safely as possible.

They can, and whether they do depends entirely on which cancer drug you are taking. Some oral cancer medicines need a certain level of stomach acid to dissolve and absorb correctly. Antacids, proton pump inhibitors such as omeprazole or pantoprazole, and H2 blockers such as famotidine reduce that acid. For some cancer drugs this matters a great deal; for others it does not. Do not assume your acidity medicine is fine without asking. If you need both, your team may advise a specific timing gap or a different acidity medicine that causes less interference.

Yes. Most GPs and specialists outside oncology do not have your full cancer drug regimen in front of them, and even when they do, checking across specialties can fall through the gaps. The safest approach is to tell the prescribing doctor which cancer drug you are on before the prescription is written, and then also inform your oncology team what has been prescribed. Two checks are better than one. If your cancer centre has an oncology pharmacist, they are particularly good at catching interactions that span specialties.

If you need treatment urgently for an infection or fever, get the treatment. Do not delay antibiotics because you cannot reach your oncology team. Tell the treating doctor which cancer drug you are on and ask them to choose an option with lower interaction risk where one is available. Then let your oncology team know as soon as possible what was prescribed. Certain antibiotics and most azole antifungals are well-established CYP3A4 interactors, and your oncologist may want to monitor you more closely or adjust your cancer drug temporarily while you complete the course.

Many standard vitamins are unlikely to cause a CYP3A4 problem, but some supplements affect absorption. Calcium supplements, for example, can bind to certain cancer drugs in the gut if taken at the same time, reducing how much of the drug actually enters your bloodstream. High-dose supplements can occasionally have other effects your team would want to know about. The practical answer: tell your team what you are taking and ask whether timing matters. For most standard vitamins, the answer will be that they are fine — but the question is worth asking rather than assuming.

Call your cancer team and tell them what you took, the dose, and when. Do not wait for your next scheduled appointment. This is not about being in trouble — it is so your team can assess whether monitoring is needed, whether your cancer drug dose should be adjusted temporarily, or whether there are specific symptoms to watch for. A single dose of most medicines is unlikely to cause a serious problem, but some interactions are significant enough that your team will want to know the same day. Being open about it is what keeps you safe.